Cornerstone Advisors, LLC Eli Lilly & CO Transaction History

Cornerstone Advisors, LLC

$2.48 Billion
Q4 2024

A detailed history of Cornerstone Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 43,600 shares of LLY stock, worth $38.1 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

43,600

Previous 43,400 0.46%

Holding current value

$38.1 Million

Previous $38.4 Million 12.46%

% of portfolio

1.36%

Previous 1.53%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$727.2 - $932.06 $145,440 - $186,412	200 Added 0.46%	43,600 $33.7 Million
Q3 2024 Nov 08, 2024	BUY	$772.14 - $960.02 $849,354 - $1.06 Million	1,100 Added 2.6%	43,400 $38.4 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $1.01 Million - $1.35 Million	-1,700 Reduced 3.86%	42,300 $32.9 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $2.89 Million - $3.41 Million	-5,500 Reduced 11.11%	44,000 $25.6 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $347,760 - $479,439	800 Added 1.64%	49,500 $26.6 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $1.16 Million - $1.55 Million	3,300 Added 7.27%	48,700 $22.8 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $10.3 Million - $12 Million	33,000 Added 266.13%	45,400 $15.6 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $29,648 - $33,787	100 Added 0.81%	12,400 $4.01 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $7.16 Million - $8.41 Million	-25,700 Reduced 67.63%	12,300 $3.99 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $6.34 Million - $7.87 Million	-27,000 Reduced 41.54%	38,000 $10.9 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $664,800 - $818,129	-3,000 Reduced 4.41%	65,000 $15 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $6.86 Million - $8.87 Million	38,000 Added 126.67%	68,000 $15.6 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $1.31 Million - $1.7 Million	8,000 Added 36.36%	30,000 $5.61 Million
Q4 2020 Feb 11, 2021	SELL	$130.46 - $172.63 $3.52 Million - $4.66 Million	-27,000 Reduced 55.1%	22,000 $3.71 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $2.92 Million - $3.38 Million	20,000 Added 68.97%	49,000 $7.25 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $545,680 - $656,720	4,000 Added 16.0%	29,000 $4.76 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $2.86 Million - $3.54 Million	-24,000 Reduced 48.98%	25,000 $3.47 Million
Q4 2019 Feb 12, 2020	BUY	$106.92 - $132.43 $5.24 Million - $6.49 Million	49,000 New	49,000 $6.44 Million

Others Institutions Holding LLY

# of Institutions

4,261

Shares Held

756M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $830B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Eli Lilly & CO Transaction History